Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 1
2021 3
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Coping with uncertainty in everyday situations (CUES©) to address intolerance of uncertainty in autistic children: an intervention feasibility trial.
Rodgers J, Goodwin J, Garland D, Grahame V, Isard L, Kernohan A, Labus M, Osborne MM, Parr JR, Rob P, Wright C, Freeston M. Rodgers J, et al. Among authors: labus m. J Autism Dev Disord. 2023 Sep;53(9):3460-3474. doi: 10.1007/s10803-022-05645-5. Epub 2022 Jul 5. J Autism Dev Disord. 2023. PMID: 35790596 Free PMC article. Clinical Trial.
HPV sensitizes OPSCC cells to cisplatin-induced apoptosis by inhibiting autophagy through E7-mediated degradation of AMBRA1.
Antonioli M, Pagni B, Vescovo T, Ellis R, Cosway B, Rollo F, Bordoni V, Agrati C, Labus M, Covello R, Benevolo M, Ippolito G, Robinson M, Piacentini M, Lovat P, Fimia GM. Antonioli M, et al. Among authors: labus m. Autophagy. 2021 Oct;17(10):2842-2855. doi: 10.1080/15548627.2020.1847444. Epub 2020 Nov 23. Autophagy. 2021. PMID: 33172332 Free PMC article.
A Randomised Controlled Feasibility Trial of Immersive Virtual Reality Treatment with Cognitive Behaviour Therapy for Specific Phobias in Young People with Autism Spectrum Disorder.
Maskey M, Rodgers J, Grahame V, Glod M, Honey E, Kinnear J, Labus M, Milne J, Minos D, McConachie H, Parr JR. Maskey M, et al. Among authors: labus m. J Autism Dev Disord. 2019 May;49(5):1912-1927. doi: 10.1007/s10803-018-3861-x. J Autism Dev Disord. 2019. PMID: 30767156 Free PMC article. Clinical Trial.
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Ewen T, Husain A, Stefanos N, Barrett P, Jones C, Ness T, Long A, Horswell S, Bosomworth H, Lowenstein J, Richardson G, Swan D, McConnell A, Rose A, Andrew T, Reynolds N, Malvehy J, Carrera C, Alos L, Mailer S, Helm T, Ding L, Bogner P, Podlipnik S, Puig S, McArthur GA, Paragh G, Labus M, Sloan P, Armstrong JL, Lovat PE. Ewen T, et al. Among authors: labus m. Br J Dermatol. 2024 Mar 15;190(4):549-558. doi: 10.1093/bjd/ljad459. Br J Dermatol. 2024. PMID: 38006317
Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
Vale L, Kunonga P, Coughlan D, Kontogiannis V, Astin M, Beyer F, Richmond C, Wilson D, Bajwa D, Javanbakht M, Bryant A, Akor W, Craig D, Lovat P, Labus M, Nasr B, Cunliffe T, Hinde H, Shawgi M, Saleh D, Royle P, Steward P, Lucas R, Ellis R. Vale L, et al. Among authors: labus m. Health Technol Assess. 2021 Nov;25(64):1-178. doi: 10.3310/hta25640. Health Technol Assess. 2021. PMID: 34792018 Free article.